Danaher Overview

  • Status
  • Public

  • Employees
  • 63,000


  • Stock Symbol
  • DHR

Stock Symbol

  • Investments
  • 85

  • Share Price
  • $262.78
  • (As of Friday Closing)

Danaher General Information


In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divesititure of its environmental and applied solutions group, Veralto.

Contact Information

Formerly Known As
Diversified Mortgage Investors, DMG, Inc.
Ownership Status
Publicly Held
Financing Status
Primary Industry
Diagnostic Equipment
Other Industries
Other Commercial Products
Stock Exchange
Corporate Office
  • 2200 Pennsylvania Avenue, North West
  • Suite 800 West
  • Washington, DC 20037
  • United States
+1 (202) 000-0000

Danaher Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Danaher Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$262.78 $261.40 $182.09 - $268.98 $195B 741M 2.59M $5.96

Danaher Financials Summary

In Thousands,
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 198,604,701 180,734,397 208,988,860 259,426,935
Revenue 22,519,000 23,890,000 26,643,000 24,802,000
EBITDA 6,702,000 7,193,000 9,441,000 8,793,000
Net Income 4,402,000 4,764,000 7,209,000 6,433,000
Total Assets 83,402,000 84,488,000 84,350,000 83,184,000
Total Debt 18,163,000 19,536,000 20,616,000 23,272,000
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Danaher Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Danaher‘s full profile, request access.

Request a free trial

Danaher Comparisons

HQ Location
Total Raised
Post Valuation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Thr
Diagnostic Equipment
Washington, DC
63,000 As of 2023
000000000 00 00.00


cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non pr
0000000000 000000000
Everett, WA
00000 As of 0000
00000000 00.00


, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo conseq
00000 0000000000 000
Oberkochen, Germany
00000 As of 0000
00.000 0000-00-00
000000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Danaher Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Fortive Corporation Everett, WA 00000 00.00 00000000 00.00
ZEISS International Formerly PE-Backed Oberkochen, Germany 00000 00.000 000000000000 00.000
3M Corporation Saint Paul, MN 00000 000.00 000000000 000.00
Bio-Rad Laboratories Corporation Hercules, CA 0000 00.000 000000000 00.000
To view Danaher’s complete competitors history, request access »

Danaher Patents

Danaher Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-2959266-B1 Quick open filling device Active 27-Apr-2010 00000000
FR-2959266-A1 Closure device for linearly displacing obturator in front of opening of case, has rotary actuator assuring linear displacement between opening and closing positions by controlling rotation of tracks Active 27-Apr-2010 00000000 0
US-20110088384-A1 Apparatus and methods for controlling hydraulically-powered apparatus Active 21-Oct-2009 0000000000 00
US-20100170817-A1 Structure of sleeve seat Inactive 05-Jan-2009 00000000 0
FR-2934438-B1 Integrated electric actuator Active 22-Jul-2008 F16H25/2252
To view Danaher’s complete patent history, request access »

Danaher Executive Team (84)

Name Title Board Seat Contact Info
Rainer Blair Chief Executive Officer, President & Board Member
Matthew McGrew Chief Financial Officer & Executive Vice President
Philip Whitehead Corporate Officer and M.D. Corporate Development EU
Christopher Bouda Chief Accounting Officer & Vice President
Jose-Carlos Gutierrez-Ramos Ph.D Chief Scientific Officer & Senior Vice President
You’re viewing 5 of 84 executive team members. Get the full list »

Danaher Board Members (15)

Name Representing Role Since
0000 00000 00 Self Board Member & Chair of the Compensation Committee 000 0000
0. 00000 0000000 Self Board Member & Member of the Audit Committee 000 0000
00000 00000000 00 Self Board Member, Member of Nominating and Governance Committee & Chair of the Science & Technology Committee 000 0000
00000 00000 Danaher Board Member & Member of the Science & Technology Committee 000 0000
0000000 0000 00 Self Board Member & Member of the Science & Technology Committee 000 0000
You’re viewing 5 of 15 board members. Get the full list »

Danaher Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Danaher Investments & Acquisitions (85)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Abcam 06-Dec-2023 0000000000 00.00 Discovery Tools (Healthcare) 000000 00
Summus 17-Aug-2023 00000 0000 000.00 Clinics/Outpatient Services
Cevec 05-Oct-2022 0000000000 Discovery Tools (Healthcare)
Summus 28-Jan-2022 00000 0000 0000 Clinics/Outpatient Services 00000000
DNA Script 04-Jan-2022 Later Stage VC 00000 Biotechnology
You’re viewing 5 of 85 investments and acquisitions. Get the full list »

Danaher Subsidiaries (38)

Company Name Industry Location Founded
Precision Nanosystems Drug Discovery Vancouver, Canada 2010
Aquatic Informatics Business/Productivity Software Vancouver, Canada 0000
Fluke Networks Internet Software Everett, WA 0000
Abcam Discovery Tools (Healthcare) Cambridge, United Kingdom 0000
Aldevron Biotechnology Fargo, ND 0000
You’re viewing 5 of 38 subsidiaries. Get the full list »

Danaher ESG

Risk Overview

Risk Rating

Updated April, 13, 2024

10.61 | Low Risk

Risk Scale

A lower score indicates better sustainability












Exposure refers to the extent to which a company is exposed to different material ESG issues



Management is related to actions taken to manage ESG issues


Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.


Covered Companies

00 of 16,421






0. of 928




Laboratory Equipment and Services


0. of 65




To view Danaher’s complete esg history, request access »

Danaher Exits (17)

Company Name Exit Date Exit Type Exit Size Status Buyers
VIA (Automotive) 11-Jun-2014 00000 00000 00 000.00 Completed
  • 5 buyers
Teletrac 02-Aug-2013 000000000000000000 Completed
  • 0000000
Navman Wireless 29-Jan-2013 000000000000000000 Completed
  • 0000000
Esko 22-Mar-2011 000000000000000000 00000 Completed
  • 0000000
Apex Tool Group 06-Jul-2010 Joint Venture Completed
  • 3 buyers
You’re viewing 5 of 17 exits. Get the full list »

Danaher FAQs

  • Who is the CEO of Danaher?

    Rainer Blair is the CEO of Danaher.

  • Where is Danaher headquartered?

    Danaher is headquartered in Washington, DC.

  • What is the size of Danaher?

    Danaher has 63,000 total employees.

  • What industry is Danaher in?

    Danaher’s primary industry is Diagnostic Equipment.

  • Is Danaher a private or public company?

    Danaher is a Public company.

  • What is Danaher’s stock symbol?

    The ticker symbol for Danaher is DHR.

  • What is the current stock price of Danaher?

    As of 24-May-2024 the stock price of Danaher is $262.78.

  • What is the current market cap of Danaher?

    The current market capitalization of Danaher is $195B.

  • What is Danaher’s current revenue?

    The trailing twelve month revenue for Danaher is $22.5B.

  • Who are Danaher’s competitors?

    Fortive, ZEISS International, 3M, and Bio-Rad Laboratories are competitors of Danaher.

  • What is Danaher’s annual earnings per share (EPS)?

    Danaher’s EPS for 12 months was $5.96.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »